
Minnetronix commercializes its own product: a minimally invasive deep brain access port
Contract developer Minnetronix Medical recently developed and commercialized its own product: MindsEye, which it says is the first minimally invasive deep brain access port. The port addresses an unmet need in the neurology market — certain forms of stroke and cancer cause lesions that are deep in the brain, and removing them can be a very invasive and dangerous process.